Horizon Quantum CSO RSUs vest; 2,991 shares sold
Chief Science Officer Dr. Tan Si-Hui reported RSU vesting, a cash settlement to Horizon Quantum, and significant RSU and stock option awards for herself and her spouse.
Rhea-AI Filing Summary
Horizon Quantum Holdings Ltd. (HQ) reported insider equity activity by Chief Science Officer Dr. Tan Si-Hui and her spouse. On September 12, 2026, 5,728 RSUs vested for Dr. Tan, converting into an equal number of Class A Ordinary Shares, followed by a disposition of 2,991 shares to the company for cash settlement at $15.22 per share. Earlier, on June 12, 2026, Dr. Tan received a grant of 91,659 RSUs that vest in sixteen approximately equal quarterly installments. Dr. Tan’s spouse received a grant of 3,600 RSUs on August 20, 2026, vesting over time, and holds 55,000 stock options with a $2.88 exercise price, exercisable in aggregate for 133,924 Class A Ordinary Shares, a portion of which is already vested and the remainder vesting in quarterly installments.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit F2, F3, F4 | 5,728 | $0.00 | $0.00 |
| Exercise | Class A Ordinary Shares F3, F4 | 5,728 | $0.00 | $0.00 |
| Disposition | Class A Ordinary Shares F5 | 2,991 | $15.22 | $46K |
| Grant/Award | Class A Ordinary Shares F1, F2 | 3,600 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Unit F2, F4 | 91,659 | $0.00 | $0.00 |
| Grant/Award | Stock Option (Right to Buy) F6, F7, F8 | 55,000 | -- | -- |
Footnotes (8)
- F1. On August 20, 2026 (the "August Grant Date"), Dr. Tan's spouse was granted a total of unvested 3,600 RSUs. The RSUs granted to Dr. Tan's spouse are subject to his continued employment with the Company and vest in accordance with the following schedule: One quarter (1/4) of the total number of RSUs vest on the first anniversary of the August Grant Date with the remaining three quarters (3/4) vesting in twelve approximately equal quarterly installments on 20th day of each fiscal quarter.
- F2. Each restricted stock unit ("RSU") represents a contingent right to receive one Class A ordinary share, with no par value ("Class A Ordinary Share"), of Horizon Quantum Holdings Ltd. (the "Company") upon vesting, for no consideration.
- F3. On September 12, 2026, 5,728 of Dr. Tan's RSU's vested.
- F4. On June 12, 2026 (the "June Grant Date"), Dr. Tan was granted a total of 91,659 unvested RSUs. The RSUs granted to Dr. Tan vest in sixteen approximately equal installments on successive quarterly anniversaries of the June Grant Date and are subject to Dr. Tan's continued employment with the Company through each applicable vesting date.
- F5. The reported disposition to the Company reflects the settlement in cash of a portion of the RSUs which vested on September 12, 2026, at a price per ordinary share of $15.22, the last reported sales price of the Company's Class A Ordinary Shares on September 11, 2026.
- F6. Each stock option has an exercise price of $2.88 and is exercisable for approximately 2.43499 Class A Ordinary Shares of the Company. In aggregate, Dr. Tan's spouse's stock options, once fully vested, are exercisable for 133,924 Class A Ordinary Shares of the Company.
- F7. Of the 55,000 stock options, 37,811 stock options are currently fully vested and exercisable. The remaining stock options vest in five approximately equal quarterly installments beginning on November 20, 2026, subject to Dr. Tan's spouse's continued employment with the Company.
- F8. As a result of the closing of the Company's business combination on March 19, 2026, Dr. Tan's spouse's 55,000 Legacy Horizon stock options were exchanged for 55,000 stock options of the Company of an equivalent economic value, with an exercise price per Class A Ordinary Share of $2.88.
Key Figures
Key Terms
Restricted Stock Unit financial
stock options financial
exercise price financial
business combination financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did HQ’s Chief Science Officer report on September 12, 2026?
What RSU grant did HQ’s Dr. Tan receive on June 12, 2026?
What RSU grant did the spouse of HQ’s Chief Science Officer receive?
What are the terms of the spouse’s stock options reported for HQ?
How was the cash settlement of Dr. Tan’s RSUs to Horizon Quantum determined?
Were HQ insider transactions reported as made under a Rule 10b5-1 trading plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.